Navigation Links
Minster Pharmaceuticals Plc Announces Positive Results from Phase II Trial of Migraine with Aura
Date:10/24/2008

ESSEX, United Kingdom, Oct. 24 /PRNewswire-FirstCall/ -- Minster Pharmaceuticals plc (AIM: MPM), the drug development company specializing in neurological and psychiatric disorders, is pleased to announce positive results from its Phase II trial in Denmark of tonabersat in the prevention of migraine with aura. The median number of aura attacks was reduced by 68% (p=0.01) in patients receiving tonabersat when compared with placebo. This result in the primary endpoint of the study is both clinically and statistically highly significant.

A further primary endpoint showed a reduction in the number of migraine headache days. This reduction did not reach statistical significance, probably owing to the small number of patients participating in the trial and, it is thought, because some of the patients suffered a type of migraine aura that is not followed by headache.

The results also showed statistically significant effects on some of the secondary endpoints including the number of attacks of migraine headache and the number of auras followed by any headache. All secondary endpoints were numerically in favor of tonabersat compared with placebo.

Migraine with aura affects around 30 percent of migraine sufferers and is a type of migraine in which the headache is preceded by symptoms such as visual disturbances and abnormalities of speech and hearing. These aura symptoms are generally recognized as being difficult to treat with existing medications.

A total of 31 patients completed the Phase II trial, which was conducted at the Danish Headache Center at Copenhagen's Glostrup University Hospital. The principal investigator in the trial was Professor Jes Olesen, the Danish Headache Center's Director and one of the world's leading authorities on headache.

Under the trial's cross-over design, patients took either tonabersat or placebo once a day for a three-month period after which the treatment regimen was reversed such that those initia
'/>"/>

SOURCE Minster Pharmaceuticals plc
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Addrenex Pharmaceuticals Initiates Phase 2 Trial on Its Novel Hypertension Drug, ADX415
2. Oramed Pharmaceuticals Launches Phase 1A Trials of its Insulin Suppository
3. Mpex Pharmaceuticals Presents New Data on MP-376 in Cystic Fibrosis
4. /K I L L K I L L K I L L -- Oramed Pharmaceuticals Inc./
5. ViroPharma Incorporated Completes Acquisition of Lev Pharmaceuticals
6. Raptor Pharmaceuticals Announces Phase 2a Clinical Trial Initiation in Non-Alcoholic Steatohepatitis (NASH)
7. Quark Pharmaceuticals Announces Publication of Study on Use of siRNA against Proprietary Target for Inhibiting Tumor Growth and Sensitization of Cancer Cells to Chemotherapy
8. Peregrine Pharmaceuticals Completes Patient Enrollment in First Stage of Its Second Bavituximab Phase II Breast Cancer Trial
9. Lilly and Deciphera Pharmaceuticals Announce Licensing and Collaboration Agreement
10. Access Pharmaceuticals Presents New Data on the Companys Angiolix(R) Therapeutic Monoclonal Antibody
11. Amylin Pharmaceuticals to Present Novel Data on Promising Obesity Pipeline at 2008 Annual Scientific Meeting of The Obesity Society

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)...- Groundbreaking articles in current issues of J...explore, in depth, the emergence of cannabinoid me...nd its potential benefits for patients. ,, In t...authors, Sunil Aggarwal, PhD who is a member of th...nd who conducted the article,s research and Gregor...
(Date:11/9/2009)...e/ -- Asthmatx, Inc. presented the results of a se...d safety of bronchial thermoplasty delivered by th...ill impact allergy practices, this past weekend in...an College of Allergy, Asthma and Immunology (ACAA..."Where Could Bronchial Thermoplasty (BT) Fit Into ...
(Date:11/9/2009)... AMD LASERS just announced that industry leading d...the position of Medical Director. In his new role...earch and development of new soft and hard tissue ...uing education credits, authoring articles for rel...uring and seminar engagements. ,, "We are very ...
Breaking Medicine Technology:Medicinal Use of Marijuana: Past, Present and Future...A Fresh Look by Experts in the Field 2Asthmatx Presents Impact of Bronchial Thermoplasty on Allergy Practices at ACAAI Annual Meeting 2Asthmatx Presents Impact of Bronchial Thermoplasty on Allergy Practices at ACAAI Annual Meeting 3AMD LASERS Names Dr. James Jesse as Medical Director 2Relievant Medsystems Announces Completion of 2420 Million Financing 4689 1Relievant Medsystems Announces Completion of 2420 Million Financing 4689 2Relievant Medsystems Announces Completion of 2420 Million Financing 4689 3Parents Guide to Cord Blood Foundation Introduces New Brochure During Cord Blood Awareness Month to Address Critical Education Gap 50861 1Parents Guide to Cord Blood Foundation Introduces New Brochure During Cord Blood Awareness Month to Address Critical Education Gap 50861 2Parents Guide to Cord Blood Foundation Introduces New Brochure During Cord Blood Awareness Month to Address Critical Education Gap 50861 3Video 3A FDA Approves Hologics Adiana 28R 29 Permanent Contraception System 50858 1Video 3A FDA Approves Hologics Adiana 28R 29 Permanent Contraception System 50858 2Video 3A FDA Approves Hologics Adiana 28R 29 Permanent Contraception System 50858 3Video 3A FDA Approves Hologics Adiana 28R 29 Permanent Contraception System 50858 4Video 3A FDA Approves Hologics Adiana 28R 29 Permanent Contraception System 50858 5
...EL HILL, N.C., Aug. 10 More than 33% of,pharmaceu...linical,investigators 50% faster than their indust...y reduce clinical trial costs while improving qual...tactics and centralized,databases, according to re...ceutical consulting firm Best Practices, LLC. Bes...
...TO, Calif., Aug. 13 BioMarin,Pharmaceutical Inc. ...results from the Kuvan(TM) (sapropterin dihydrochl...ed in the August 11, 2007, issue of The Lancet.,Th... in significant,reductions in blood Phe levels in ...estigational oral small molecule for the treatment...
Other Medicine Technology:Clinical Trial Effectiveness: How Pharmas & Biotechs Save Cost with Savvy Investigator Management 2Positive Kuvan(TM) Pivotal Phase 3 Trial Results Published in The Lancet 2Positive Kuvan(TM) Pivotal Phase 3 Trial Results Published in The Lancet 3Positive Kuvan(TM) Pivotal Phase 3 Trial Results Published in The Lancet 4Positive Kuvan(TM) Pivotal Phase 3 Trial Results Published in The Lancet 5
(Date:11/9/2009)...Names 2010 National Ambassador ,, WHITE PLAIN...Hoffman of Weston, Fla., was born so early and wit... not say whether he would survive -- or if he woul...old was named March of Dimes 2010 National Ambassa..., "My first minutes of motherhood and I was comple...
(Date:11/9/2009)...PRNewswire-USNewswire/ -- For the third consecutiv... been selected the most preferred hospital for can...vey by the National Research Corporation. ,, (...06/KARMANOSLOGO ) ,, The annual survey was con...ember 2008 and August 2009. Survey respondents wer...
(Date:11/9/2009)...e people went from incapacitated to working again,...-- Electrical stimulation of a certain area of the... depression, say German researchers. , They imp... the brains of 10 people. This area of the brain ...ple remember good experiences and puts them in a s...
(Date:11/9/2009).../PRNewswire/ -- Phoenix House , the nation,s ...t and prevention program, announced today its appo...ternationally recognized leader in substance abuse..., effective January 1, 2010. ,, "Dr. Deni Car...eatment research and her work has resulted in a si...
(Date:11/9/2009)... Nov. 9 New Mayo Clinic...inal prolapse dramatically reduces patient hospi...ng presented this week at the North Central Sectio...dale, Ariz. ,, (Logo: http://www.newscom.com...LERT : Additional audio and video resources, inclu...
Breaking Medicine News(10 mins):Health News:Six-Year-Old Survivor Fights for Preemies Like Himself 2Health News:Six-Year-Old Survivor Fights for Preemies Like Himself 3Health News:Karmanos Cancer Center Most Preferred Hospital for Cancer Care in Southeast Michigan, Third Consecutive Year 2Health News:Brain Stimulation May Ease Treatment-Resistant Depression 2Health News:Phoenix House Appoints Dr. Deni Carise as Chief Clinical Officer - Internationally Recognized Leader in Substance Abuse Treatment and Research 2Health News:Phoenix House Appoints Dr. Deni Carise as Chief Clinical Officer - Internationally Recognized Leader in Substance Abuse Treatment and Research 3Health News:Mayo Researchers Find Robotic Repair for Vaginal Prolapse Has Significant Benefits 2Health News:Mayo Researchers Find Robotic Repair for Vaginal Prolapse Has Significant Benefits 3
... After years of emotional debate, US health author...contraceptive pill without a prescription for wome...ill need a prescription from a physician, the Food...egnancy if used within days of unprotected sex. ...
... Education is a panacea for many ills and who know...public campaign rolling, to inform the public abou...naphylaxis. Anaphylaxis can actually desce...ich is the cause of nearly 1,500 deaths in the Uni...
... Scientists at the Indian Council of Agricultural ...eat, which will be beneficial for diabetics becaus... that keep in check cholesterol levels in blood ca...ltural Sciences developed the Dicoccum variety cal...
... Obesity experts say that just increasing the time...at they will get more action and thus reduce weigh...nd colleagues found in a new study that government...00 teens in grades nine through 12. All students h...
... A cancer-killing compound called rasfonin has bee...is fungus was discovered the walls of a New Zealan...ses the cancer cells to commit suicide while not h... agent, but no one has been able to study or devel...
... Health experts are optimistic that ill health and...elegated to the past. // According to Alan ...cience, if the partners of the global health partn...ould be confined to pages in history. Profes...
Other Medicine News:Health News:Cancer-Killing Compound From A Fungus 2Health News:Experts Are Optimistic Of Making Waterborne Infectious Diseases A Thing Of Past 2
...UP Laboratories is a national reference laboratory...esearch and development. ARUP offers an extensive ...ts in clinical and anatomic pathology. Owned by th...nclude more than half of the nation's university t...
...UP Laboratories is a national reference laboratory...esearch and development. ARUP offers an extensive ...ts in clinical and anatomic pathology. Owned by th...nclude more than half of the nation's university t...
...UP Laboratories is a national reference laboratory...esearch and development. ARUP offers an extensive ...ts in clinical and anatomic pathology. Owned by th...nclude more than half of the nation's university t...
...UP Laboratories is a national reference laboratory...esearch and development. ARUP offers an extensive ...ts in clinical and anatomic pathology. Owned by th...nclude more than half of the nation's university t...
Medicine Products: